Morning Business News :
- Sebi Rejigs IPO Norms; Halves Listing Time To 6 Days
- India To Inject About $3 Bn This Fiscal Year In State-Owned Banks
- RIL Investors Concerned Over Its Media, Telecom Bets
- Infosys Grants 124,061 Restricted Stock Units To Vishal Sikka
- 3M Buying Capital Safety From KKR For $1.8 Bn
- Top BSE Stakeholder Urges FM To Review Exchange Norms
- El Nino Phenomenon To Have No Impact On Monsoon Rains: Expert
- FMC’s Merger With SEBI By September
- Govt Notifies New, Simplified Incom Tax Returns Forms
- Private Sector Investments Imperative For Growth: Jaitley
- Co-Payment In Health Insurance Only After Netting Hospital Discounts, Says IRDAI
- RIL, ONGC, SBI, BHEL, L&T Could Be Out Of Sensex In 10 Years: Ambit Capital
- GMR Infrastructure Seeks Loan Recast Under 5/25 Scheme
- ECB Raises Emergency Funding For Greek Banks
- Jaitley Hints At Joint Session Of Parliament
- FSSAI Extends Ban On Chinese Milk Products
- Concluding Trade Pact With India Is Australia’s Top Priority: Andrew Robb
- BHEL Commissions 250-MW Thermal Unit In Assam
- Softbank Keen On Working With AP In Renewable Energy Sector
- Sebi Approves Trading Platform For Start-Ups
- Investments Surge In India’s Telecom Industry
- All Tax Refunds To Be Put Directly In Bank Accounts, Says CBDT
- L&T Infotech To List On Exchanges By December 2015: Report
- Videocon Will Be An Oil And Gas Firm In Three Years
- Govt Mulls Roping In States For Commercial Mining Of Coal
- Fin Ministry Reduces Penalty For Customs Duty Fraud By 10%
- Govt Has Not Decided On Recapitalisation Figures For Banks: Arun Jaitley
- Greece Debt Crisis: 11 Keypoints In Alexis Tsipras’s Cash-For-Reform Proposals
- Blackberry First Quarter Software Revenue Jumps To $137 Mn
- Ashok Leyland Wins $82 Mn Bus Contract From Senegal
- Mkts Extend Gain On Above-Normal Monsoon, Global Cues
- Indian Biz Sentiment Boosted By June Rate Cut: Study
- 85% Indian Retailers Use Emails For Customer Outreach
- RBI External Panel Members Backed Rate Cuts At June Meet
- Mahindras Launch Jeeto CV, To Invest `150 Crore
- Jubilant Gets USFDA Nod For Generic Levofloxacin Tablets